太龙药业: 太龙药业关于董事会换届选举的公告

Core Viewpoint - The announcement details the election of the 10th Board of Directors for Henan Tailong Pharmaceutical Co., Ltd., following the expiration of the 9th Board's term, in compliance with relevant laws and regulations [1][2]. Board Election Summary - The 9th Board of Directors held its 33rd meeting on July 30, 2025, where it approved the nomination of candidates for the 10th Board, including both non-independent and independent directors [1][2]. - The nominated non-independent directors are Wang Rongtao, Li Jingliang, Chen Siliang, Chen Jinge, and Luo Jiancao, while the independent director candidates are Chen Qi, Liu Yumin, and Fang Liang [2][3]. - The independent director candidates have obtained the necessary qualifications and meet the requirements set forth by relevant regulations [2][3]. Voting Process - The election of the new Board will be conducted at the shareholders' meeting using a cumulative voting system for both independent and non-independent directors [3]. - Once approved by the shareholders, the new Board will serve a term of three years starting from the date of approval [3]. Transition Period - The current 9th Board will continue to perform its duties until the new Board is officially in place, ensuring the company's operations remain uninterrupted [3].